Take in Non-CME Industry Symposia at ATS 2014

The ATS encourages Non-CME Industry Symposia in conjunction with the International Conference. All full-conference participants are encouraged to attend these programs.

6:30 to 9:30 p.m.
Manchester Grand Hyatt: Coronado Ballroom A-B-C (4th Level)
Advances in Parenteral Therapy for Patients with Pulmonary Arterial Hypertension
Speakers: Ioana Preston, M.D., Associate Professor of Medicine, Tufts University School of Medicine; Co-Director Pulmonary Hypertension Center, Tufts Medical Center; Robert J. Schilz, D.O., Ph.D., F.C.C.P., Interim Chair of Pulmonary, Critical Care and Sleep Medicine, Co-Director of Lung Transplantation, Director of Pulmonary Vascular Disease, University Hospitals Case Medical Center; Sean Studer, M.D., Chief of Medicine, Clinical Associate Professor, New York University; R. James White, M.D., Ph.D., Associate Professor of Medicine, Pharmacology & Physiology, University of Rochester Medical Center
To Register for this program, please visit: www.advancesinPAH.com
Organizer: United Therapeutics Corporation

6:30 to 9:30 p.m.
Manchester Grand Hyatt: Coronado Ballroom D-E (4th Level)
Anti-inflammatory Effect of ICS/LABA Combination Therapy: Role in COPD Treatment
(Open to U.S. attendees only)
Organizer: AstraZeneca

6:30 to 9:30 p.m.
Manchester Grand Hyatt: Grand Ballroom A (Lobby Level)
Experts in PAH Explore: Practical Approaches to Treatment in a Clinical Setting
6:30 p.m.: Registration & Buffet Dinner
7 to 9 p.m.: Interactive Session
Experts in PAH Explore: Practical Approaches to Treatment in a Clinical Setting is a dinner symposium sponsored by Gilead Sciences, Inc. The program is open to all ATS 2014 International Conference attendees. A faculty of experts in PAH will explore current and compelling topics, in the context of several patient scenarios. Faculty will share perspectives around diagnosis, assessment of disease severity, treatment selection in a clinical setting, and following the patient’s progress. The session will provide a highly interactive forum and engage program participants.

Speakers: Mardi Gomberg-Maitland, MD, MSc, University of Chicago; Ronald Oudiz, MD, LA Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA; and Jeremy Feldman, MD, Arizona Pulmonary Specialists, Phoenix
Organizer: Gilead Sciences, Inc. 

6:30 to 9:30 p.m.
Manchester Grand Hyatt: Harbor Ballroom D-I (Second Level)
A New Era in IPF: Trials and Treatments 
This dinner symposium will address new results in the treatment of IPF. The major focus will be comparing and interpreting recent clinical trial results. A detailed discussion of how to incorporate study results into clinical practice will be moderated by Dr. Steven Nathan and will cover the PANTHER, ASCEND, and INPULSIS trials. Results from each of these trials will be announced just hours before this symposium so the expert discussion will be timely and exciting. Other topics to be addressed in light of the clinical trial results include timing of treatment, models of disease progression, and criteria for clinical success in IPF.
Organizer: The France Foundation

6:30 to 9:30 p.m.
Manchester Grand Hyatt: Grand Ballroom C (Lobby Level)
Where Innovation Meets Patient Needs: Debating the Future of Respiratory Medicine
(Open to International Attendees only)

  • Review the growing need for individualized treatments in heterogeneous asthma and COPD patient cohorts
  • Demonstrate how inhaled bronchodilators in fixed-dose and triple combinations, and innovative new technologies can improve treatment in COPD patients
  • Understand the evolving definition of asthma and how molecular approaches can improve future treatment options for asthmatic phenotypes
  • Discuss how biologic treatment options can target unmet need in asthma patients with eosinophilic phenotypes
  • Debate how individualized treatments can enhance the future of respiratory medicine

Organizer: AstraZeneca

6:30 to 9:30 p.m.
San Diego Marriott Marquis & Marina: Marina Ballroom D-E (South Tower, 3rd Level)
Treating PAH and CTEPH: Case Study Discussions
Speakers: Nicholas S. Hill, MD, FCCP (chair), professor of medicine, Tufts University School of Medicine, Boston; Nick H. Kim, MD, associate clinical professor of medicine, University of California San Diego School of Medicine, San Diego; and Roham T. Zamanian, MD, FCCP, assistant professor of medicine, Stanford University Medical Center, Stanford, CA 
Organizer: Bayer HealthCare Pharmaceuticals

6:30 to 9:30 p.m.
San Diego Marriott Marquis & Marina: Marina Ballroom F-G (South Tower, 3rd Level)
Identifying the Unmet Needs in Asthma: Who, Why, and How Many?
(Open to International Attendees only)
Explore the burden of chronic symptomatic asthma given current treatments and why it persists.
To assess the role of phenotyping, biologicals, long-acting bronchodilators, and other emergent treatments.
Symposium chair: Eric D Bateman
Speakers: Eric D Bateman, South Africa; Timothy Harrison, United Kingdom; Paul O’Byrne, Canada; and Huib Kerstjens, The Netherlands
Organizer: Boehringer Ingelheim Pharma GmbH RCO KG

6:30 to 9:30 p.m.
Manchester Grand Hyatt: Coronado Ballroom A- B- C (4th Level)
The Significance of Uncovering and Managing Severe Pulmonary Infections
in Your Practice

How do you recognize patients with a serious pulmonary infectious disease to diagnose quickly and accurately? Do you rely on guidelines to shape your treatment decisions? Listen to clinical experts discuss serious pulmonary infectious disease and essential approaches to recognition, diagnosis, treatment, and the consequences of underdiagnosing. Learn how to implement or enhance best approaches in your own practice—from the experts.Organizer: Insmed 

6:30 to 9:30 p.m.
San Diego Marriott Marquis & Marina: Marina Ballroom E-F-G (South Tower, 3rd Level)
Pulmonary Arterial Hypertension: An Evidence-based Discussion With
the Experts

Pulmonary arterial hypertension (PAH) is a chronic, progressive disease characterized by restricted flow through the pulmonary arterial circulation which leads to increases in pulmonary vascular resistance and, ultimately, right heart failure. The science and clinical management of PAH has advanced significantly in recent years and continues to do so. During this symposium, a panel of experts will explore and discuss current concepts in the clinical management of PAH in the context of 2 case study presentations.
Dinner will be provided. Dinner will not be provided to physicians and other healthcare professionals licensed in Vermont or other states where gifts and meals are prohibited. Dinner provided to physicians will be subject to reporting in accordance with Federal Law.
Speakers: Nick Kim, MD, program chair, University of California, San Diego, La Jolla, California; Sean Studer, MD, NYU-Woodhull Medical Center, Brooklyn, NY; and Paul Forfia, MD, Temple University Hospital, Philadelphia
Organizer: Actelion Pharmaceuticals US, Inc.